comprehensive -WSS

comprehensive

author：fashion 2025-09-01 15:21:18 - browse：88

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Pregnancy discrimination could be enabled by AI

Wikipedia

WSS

Physician groups backed by private equity giant lobby on mergers

Breakthrough Alzheimer’s drugs are inaccessible in rural states

EQRx, failed developer of low

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Trump indictment: Who are the 'co

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

focus

comprehensive

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

New safety details link Apellis eye drug to rare cases of blindness

Hollywood unions extend contract negotiations for actors

Pfizer plans to depart BIO

How one medical school became remarkably diverse

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Medical leaders decry Supreme Court decision on affirmative action

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Jerome Adams on the need for new antivirals for Covid

The high personal cost of affirmative action for Black doctors

focus

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Amazon expands telehealth clinic nationwide

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

No plane should take off without an EpiPen onboard

What to expect as Trump is arraigned on his Jan 6. indictment

‘Oppenheimer’ and the risks of AI in health care

hotspot

Wikipedia

focus

hotspot